Mucotis-AB Tablet is a combined therapeutic agent containing Acebrophylline (100mg) and Acetylcysteine (600mg). Indicated for the treatment of chronic bronchitis, emphysema, and other obstructive airway diseases, Mucotis-AB offers a twofold approach to symptom management. Acebrophylline, a theophylline derivative, acts as a bronchodilator and enhances mucociliary clearance, improving airflow and reducing bronchoconstriction. Simultaneously, Acetylcysteine, a mucolytic agent, aids in the dissolution and mobilization of thick bronchial secretions, reducing viscosity and facilitating their expulsion. The synergistic action of these components in Mucotis-AB Tablet contributes to an overall improvement in pulmonary function and alleviation of respiratory symptoms in affected individuals.